IRONWOOD PHARMACEUTICALS, INC. Estimated Litigation Liability, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Estimated Litigation Liability, Current of $5.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2026-08-06
- 2026-06-30: Estimated Litigation Liability, Current $5.00M.
- 2026-03-31: Estimated Litigation Liability, Current $5.00M.
- 2025-12-31: Estimated Litigation Liability, Current $5.00M.
- 2025-09-30: Estimated Litigation Liability, Current $7.50M.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.00M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.50M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |